| 1 | Early Manifestations of Neurodevelopmental Copy Number Variants in Children: A Population-Based Investigation | 5.4 | 11 | Citations (PDF) |
| 2 | Association between genetic liability to physical health conditions and comorbidities in individuals with severe mental illness: an analysis of two cross-sectional observational studies in the UK | 17.3 | 5 | Citations (PDF) |
| 3 | Antipsychotic and pharmacogenomic effects on cross-sectional symptom severity and cognitive ability in schizophrenia | 9.7 | 4 | Citations (PDF) |
| 4 | Effects of Shared and Nonshared Schizophrenia and Bipolar Disorder Alleles on Cognition and Educational Attainment in the UK Biobank | 2.7 | 3 | Citations (PDF) |
| 5 | Rare variants in pharmacogenes influence clozapine metabolism in individuals with schizophrenia | 1.0 | 11 | Citations (PDF) |
| 6 | Impaired oxysterol-liver X receptor signaling underlies aberrant cortical neurogenesis in a stem cell model of neurodevelopmental disorder | 6.3 | 10 | Citations (PDF) |
| 7 | Using rare genetic mutations to revisit structural brain asymmetry | 13.7 | 7 | Citations (PDF) |
| 8 | Linking haploinsufficiency of the autism- and schizophrenia-associated gene Cyfip1 with striatal-limbic-cortical network dysfunction and cognitive inflexibility | 5.2 | 6 | Citations (PDF) |
| 9 | Irritability in young people with copy number variants associated with neurodevelopmental disorders (ND-CNVs) | 5.2 | 1 | Citations (PDF) |
| 10 | Severe psychiatric disorders are associated with increased risk of dementia | 2.8 | 24 | Citations (PDF) |
| 11 | F19. INTERNALISING AND CARDIOMETABOLIC MULTIMORBIDITY IN OLDER-AGED INDIVIDUALS WITH NEURODEVELOPMENTAL COPY NUMBER VARIANTS: ANALYSIS IN A POPULATION-BASED COHORT | 1.0 | 0 | Citations (PDF) |
| 12 | The genetics of cognition in schizophrenia 2024, 1, 28-35 | | 9 | Citations (PDF) |
| 13 | Genetic risk for schizophrenia is associated with increased proportion of indirect connections in brain networks revealed by a semi-metric analysis: evidence from population sample stratified for polygenic risk | 2.8 | 4 | Citations (PDF) |
| 14 | Brain functional connectivity mirrors genetic pleiotropy in psychiatric conditionsBrain, 2023, 146, 1686-1696 | 8.4 | 20 | Citations (PDF) |
| 15 | Copy Number Variants Increasing Risk for Schizophrenia: Shared and Distinct Effects on Brain Morphometry and Cognitive Performance | 2.7 | 1 | Citations (PDF) |
| 16 | Psychopathology in mothers of children with pathogenic Copy Number Variants | 3.8 | 4 | Citations (PDF) |
| 17 | Rare CNVs and phenome-wide profiling highlight brain structural divergence and phenotypical convergence | 9.1 | 24 | Citations (PDF) |
| 18 | Rare coding variants as risk modifiers of the 22q11.2 deletion implicate postnatal cortical development in syndromic schizophrenia | 7.8 | 5 | Citations (PDF) |
| 19 | Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations | 25.2 | 76 | Citations (PDF) |
| 20 | Family-based analysis of the contribution of rare and common genetic variants to school performance in schizophrenia | 7.8 | 12 | Citations (PDF) |
| 21 | Atypical cortical networks in children at high-genetic risk of psychiatric and neurodevelopmental disorders | 5.4 | 7 | Citations (PDF) |
| 22 | Chromatin regulators in the TBX1 network confer risk for conotruncal heart defects in 22q11.2DS | 4.3 | 12 | Citations (PDF) |
| 23 | Genomic findings in schizophrenia and their implications | 7.8 | 161 | Citations (PDF) |
| 24 | THE ROLE OF GENOMIC MARKERS AS POTENTIAL PREDICTORS OF TREATMENT OUTCOMES IN SCHIZOPHRENIA: PREDICTIVE MODELLING OF CLOZAPINE DOSES AND METABOLISM | 1.0 | 0 | Citations (PDF) |
| 25 | W78. PSYCHOTIC DISORDER DIAGNOSES: ARE THEY ALL THE SAME? | 1.0 | 0 | Citations (PDF) |
| 26 | T91. COMPARISON OF PATHWAY-BASED POLYGENIC SCORES BETWEEN SCHIZOPHRENIA CARRIERS AND NON-CARRIERS OF HIGH IMPACT DE NOVO VARIANTS | 1.0 | 0 | Citations (PDF) |
| 27 | W91. A SCHIZOPHRENIA MISSENSE VARIANT IN SLC39A8 IS ASSOCIATED WITH POORER COGNITIVE ABILITY: A CROSS SECTIONAL STUDY OF RS13107325 | 1.0 | 0 | Citations (PDF) |
| 28 | T21. A GENETIC EXPLORATION OF DEFINITIONS OF INTERNALISING DISORDERS IN UK BIOBANK | 1.0 | 0 | Citations (PDF) |
| 29 | Mediation and longitudinal analysis to interpret the association between clozapine pharmacokinetics, pharmacogenomics, and absolute neutrophil count | 3.1 | 2 | Citations (PDF) |
| 30 | Rare genetic brain disorders with overlapping neurological and psychiatric phenotypes | 28.6 | 29 | Citations (PDF) |
| 31 | Rare X-linked variants carry predominantly male risk in autism, Tourette syndrome, and ADHD | 13.7 | 20 | Citations (PDF) |
| 32 | Effects of copy number variations on brain structure and risk for psychiatric illness: Large‐scale studies from theENIGMAworking groups onCNVs | 3.5 | 67 | Citations (PDF) |
| 33 | Lack of Support for the Genes by Early Environment Interaction Hypothesis in the Pathogenesis of Schizophrenia | 3.9 | 29 | Citations (PDF) |
| 34 | Identifying the Common Genetic Basis of Antidepressant Response | 2.7 | 122 | Citations (PDF) |
| 35 | Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors | 5.4 | 239 | Citations (PDF) |
| 36 | Complement C3 and C3aR mediate different aspects of emotional behaviours; relevance to risk for psychiatric disorder | 4.5 | 26 | Citations (PDF) |
| 37 | The nature of schizophrenia: As broad as it is long | 2.3 | 10 | Citations (PDF) |
| 38 | Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia | 12.4 | 104 | Citations (PDF) |
| 39 | Transcriptional programs regulating neuronal differentiation are disrupted in DLG2 knockout human embryonic stem cells and enriched for schizophrenia and related disorders risk variants | 13.7 | 27 | Citations (PDF) |
| 40 | Mapping genomic loci implicates genes and synaptic biology in schizophrenia | 37.9 | 2,685 | Citations (PDF) |
| 41 | Rare coding variants in ten genes confer substantial risk for schizophrenia | 37.9 | 867 | Citations (PDF) |
| 42 | Exome sequencing in bipolar disorder identifies AKAP11 as a risk gene shared with schizophrenia | 25.2 | 211 | Citations (PDF) |
| 43 | Schizophrenia Polygenic Risk and Experiences of Childhood Adversity: A Systematic Review and Meta-analysis | 3.9 | 42 | Citations (PDF) |
| 44 | Machine learning for prediction of schizophrenia using genetic and demographic factors in the UK biobank | 2.3 | 30 | Citations (PDF) |
| 45 | Ultrarare Coding Variants and Cognitive Function in Schizophrenia | 12.4 | 16 | Citations (PDF) |
| 46 | T106. ASSESSING THE VALIDITY OF METHODS TO REPORT A SCHIZOPHRENIA DIAGNOSIS | 1.0 | 0 | Citations (PDF) |
| 47 | NRSF/REST lies at the intersection between epigenetic regulation, miRNA-mediated gene control and neurodevelopmental pathways associated with Intellectual disability (ID) and Schizophrenia | 5.2 | 18 | Citations (PDF) |
| 48 | The Contribution of the Rüdin School to Psychiatric Genetics: The Light and the Darkness | 3.9 | 0 | Citations (PDF) |
| 49 | A Genetics-First Approach to Dissecting the Heterogeneity of Autism: Phenotypic Comparison of Autism Risk Copy Number Variants | 8.8 | 96 | Citations (PDF) |
| 50 | Neurotrophin receptor activation rescues cognitive and synaptic abnormalities caused by hemizygosity of the psychiatric risk gene Cacna1c | 7.8 | 29 | Citations (PDF) |
| 51 | Prioritizing Genetic Contributors to Cortical Alterations in 22q11.2 Deletion Syndrome Using Imaging Transcriptomics | 2.8 | 14 | Citations (PDF) |
| 52 | The psychiatric phenotypes of 1q21 distal deletion and duplication | 5.2 | 13 | Citations (PDF) |
| 53 | 1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans | 5.2 | 38 | Citations (PDF) |
| 54 | Association of genetic liability for psychiatric disorders with accelerometer-assessed physical activity in the UK Biobank | 2.3 | 33 | Citations (PDF) |
| 55 | A normative chart for cognitive development in a genetically selected population | 5.4 | 20 | Citations (PDF) |
| 56 | Clozapine Metabolism is Associated With Absolute Neutrophil Count in Individuals With Treatment-Resistant Schizophrenia | 3.8 | 22 | Citations (PDF) |
| 57 | Risk Factors, Clinical Features, and Polygenic Risk Scores in Schizophrenia and Schizoaffective Disorder Depressive-Type | 3.9 | 15 | Citations (PDF) |
| 58 | Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology | 25.2 | 1,502 | Citations (PDF) |
| 59 | Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study | 7.8 | 29 | Citations (PDF) |
| 60 | Genome-wide analyses of smoking behaviors in schizophrenia: Findings from the Psychiatric Genomics Consortium | 2.9 | 17 | Citations (PDF) |
| 61 | Haploinsufficiency of the schizophrenia and autism risk gene Cyfip1 causes abnormal postnatal hippocampal neurogenesis through microglial and Arp2/3 mediated actin dependent mechanisms | 5.2 | 28 | Citations (PDF) |
| 62 | Using induced pluripotent stem cells to investigate human neuronal phenotypes in 1q21.1 deletion and duplication syndrome | 7.8 | 29 | Citations (PDF) |
| 63 | Clinical evaluation of patients with a neuropsychiatric risk copy number variant | 3.2 | 26 | Citations (PDF) |
| 64 | Effects of eight neuropsychiatric copy number variants on human brain structure | 5.2 | 42 | Citations (PDF) |
| 65 | Rare Copy Number Variants Are Associated With Poorer Cognition in Schizophrenia | 5.4 | 37 | Citations (PDF) |
| 66 | Associations Between Schizophrenia Polygenic Liability, Symptom Dimensions, and Cognitive Ability in Schizophrenia | 12.4 | 93 | Citations (PDF) |
| 67 | Developmental Profile of Psychiatric Risk Associated With Voltage-Gated Cation Channel Activity | 5.4 | 25 | Citations (PDF) |
| 68 | Schizophrenia, autism spectrum disorders and developmental disorders share specific disruptive coding mutations | 13.7 | 95 | Citations (PDF) |
| 69 | Global Brain Flexibility During Working Memory Is Reduced in a High-Genetic-Risk Group for Schizophrenia | 1.2 | 8 | Citations (PDF) |
| 70 | Investigating rare pathogenic/likely pathogenic exonic variation in bipolar disorder | 7.8 | 18 | Citations (PDF) |
| 71 | Pharmacogenomics: A road ahead for precision medicine in psychiatry | 11.0 | 73 | Citations (PDF) |
| 72 | Post-partum psychosis and its association with bipolar disorder in the UK: a case-control study using polygenic risk scores | 17.3 | 32 | Citations (PDF) |
| 73 | Genetic risk for schizophrenia is associated with altered visually-induced gamma band activity: evidence from a population sample stratified polygenic risk | 5.2 | 7 | Citations (PDF) |
| 74 | Characterization of Single Gene Copy Number Variants in Schizophrenia | 5.4 | 10 | Citations (PDF) |
| 75 | Association of Copy Number Variation of the 15q11.2 BP1-BP2 Region With Cortical and Subcortical Morphology and Cognition | 12.4 | 83 | Citations (PDF) |
| 76 | A transcriptome-wide association study implicates specific pre- and post-synaptic abnormalities in schizophrenia | 2.9 | 74 | Citations (PDF) |
| 77 | A Population-Based Cohort Study Examining the Incidence and Impact of Psychotic Experiences From Childhood to Adulthood, and Prediction of Psychotic Disorder | 8.8 | 171 | Citations (PDF) |
| 78 | The Duffy-null genotype and risk of infection | 2.9 | 43 | Citations (PDF) |
| 79 | Genetic association of FMRP targets with psychiatric disorders | 7.8 | 29 | Citations (PDF) |
| 80 | Electrophysiological network alterations in adults with copy number variants associated with high neurodevelopmental risk | 5.2 | 14 | Citations (PDF) |
| 81 | Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome | 33.0 | 136 | Citations (PDF) |
| 82 | Cis-effects on gene expression in the human prenatal brain associated with genetic risk for neuropsychiatric disorders | 7.8 | 37 | Citations (PDF) |
| 83 | Movement Disorder Phenotypes in Children With 22q11.2 Deletion Syndrome | 4.6 | 15 | Citations (PDF) |
| 84 | A brief report: de novo copy number variants in children with attention deficit hyperactivity disorder | 5.2 | 24 | Citations (PDF) |
| 85 | The mutational constraint spectrum quantified from variation in 141,456 humans | 37.9 | 9,543 | Citations (PDF) |
| 86 | Transcript expression-aware annotation improves rare variant interpretation | 37.9 | 193 | Citations (PDF) |
| 87 | S178. SHOULD SCHIZOAFFECTIVE DISORDER DEPRESSED-TYPE BE DISTINCT FROM SCHIZOPHRENIA? ANALYSIS OF GENETIC LIABILITY AND LIFETIME CLINICAL CHARACTERISTICS | 3.9 | 2 | Citations (PDF) |
| 88 | Response to letter to editor: “Knowing when and how to use epilepsy screening questionnaires” | 4.4 | 0 | Citations (PDF) |
| 89 | Reinforcement learning as an intermediate phenotype in psychosis? Deficits sensitive to illness stage but not associated with polygenic risk of schizophrenia in the general population | 2.3 | 28 | Citations (PDF) |
| 90 | A Mendelian randomization study of the causal association between anxiety phenotypes and schizophrenia | 1.5 | 14 | Citations (PDF) |
| 91 | Cognitive deficits in childhood, adolescence and adulthood in 22q11.2 deletion syndrome and association with psychopathology | 5.2 | 51 | Citations (PDF) |
| 92 | Genome-wide association study of dietary intake in the UK biobank study and its associations with schizophrenia and other traits | 5.2 | 46 | Citations (PDF) |
| 93 | Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric Illness | 8.8 | 88 | Citations (PDF) |
| 94 | De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia | 17.1 | 129 | Citations (PDF) |
| 95 | Translating insights from neuropsychiatric genetics and genomics for precision psychiatry | 9.6 | 76 | Citations (PDF) |
| 96 | Area deprivation, urbanicity, severe mental illness and social drift — A population-based linkage study using routinely collected primary and secondary care data | 2.3 | 40 | Citations (PDF) |
| 97 | Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion | 7.8 | 120 | Citations (PDF) |
| 98 | Conditional GWAS analysis to identify disorder-specific SNPs for psychiatric disorders | 7.8 | 70 | Citations (PDF) |
| 99 | Cyfip1 haploinsufficient rats show white matter changes, myelin thinning, abnormal oligodendrocytes and behavioural inflexibility | 13.7 | 71 | Citations (PDF) |
| 100 | Using kinematic analyses to explore sensorimotor control impairments in children with 22q11.2 deletion syndrome | 3.3 | 8 | Citations (PDF) |
| 101 | The Relationship Between Common Variant Schizophrenia Liability and Number of Offspring in the UK Biobank: Response to Lawn et al. | 8.8 | 5 | Citations (PDF) |
| 102 | Association of Genetic Liability to Psychotic Experiences With Neuropsychotic Disorders and Traits | 12.4 | 158 | Citations (PDF) |
| 103 | Psychiatric disorders in children with 16p11.2 deletion and duplication | 5.2 | 150 | Citations (PDF) |
| 104 | GWAS of Suicide Attempt in Psychiatric Disorders and Association With Major Depression Polygenic Risk Scores | 8.8 | 262 | Citations (PDF) |
| 105 | Genotype–phenotype associations in children with copy number variants associated with high neuropsychiatric risk in the UK (IMAGINE-ID): a case-control cohort study | 17.3 | 129 | Citations (PDF) |
| 106 | Novel Insight Into the Etiology of Autism Spectrum Disorder Gained by Integrating Expression Data With Genome-wide Association Statistics | 5.4 | 79 | Citations (PDF) |
| 107 | Genome-wide association study identifies 30 loci associated with bipolar disorder | 25.2 | 1,531 | Citations (PDF) |
| 108 | Gene expression imputation across multiple brain regions provides insights into schizophrenia risk | 25.2 | 201 | Citations (PDF) |
| 109 | Epilepsy and seizures in young people with 22q11.2 deletion syndrome: Prevalence and links with other neurodevelopmental disorders | 4.4 | 46 | Citations (PDF) |
| 110 | Dynamic expression of genes associated with schizophrenia and bipolar disorder across development | 5.2 | 51 | Citations (PDF) |
| 111 | Genetic risk for schizophrenia and developmental delay is associated with shape and microstructure of midline white-matter structures | 5.2 | 28 | Citations (PDF) |
| 112 | Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing | 25.2 | 2,971 | Citations (PDF) |
| 113 | Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric DisordersCell, 2019, 179, 1469-1482.e11 | 33.6 | 1,397 | Citations (PDF) |
| 114 | Reciprocal White Matter Changes Associated With Copy Number Variation at 15q11.2 BP1-BP2: A Diffusion Tensor Imaging Study | 5.4 | 35 | Citations (PDF) |
| 115 | Convergent Evidence That ZNF804A Is a Regulator of Pre-messenger RNA Processing and Gene Expression | 3.9 | 28 | Citations (PDF) |
| 116 | Targeted Sequencing of 10,198 Samples Confirms Abnormalities in Neuronal Activity and Implicates Voltage-Gated Sodium Channels in Schizophrenia Pathogenesis | 5.4 | 50 | Citations (PDF) |
| 117 | The emergence of psychotic experiences in the early adolescence of 22q11.2 Deletion Syndrome | 2.9 | 28 | Citations (PDF) |
| 118 | The Relationship Between Common Variant Schizophrenia Liability and Number of Offspring in the UK Biobank | 8.8 | 12 | Citations (PDF) |
| 119 | A genome-wide association study in individuals of African ancestry reveals the importance of the Duffy-null genotype in the assessment of clozapine-related neutropenia | 7.8 | 68 | Citations (PDF) |
| 120 | Medical consequences of pathogenic CNVs in adults: analysis of the UK Biobank | 3.8 | 176 | Citations (PDF) |
| 121 | Genetic Variation in the Psychiatric Risk Gene CACNA1C Modulates Reversal Learning Across Species | 3.9 | 29 | Citations (PDF) |
| 122 | Structural and Functional Neuroimaging of Polygenic Risk for Schizophrenia: A Recall-by-Genotype–Based Approach | 3.9 | 44 | Citations (PDF) |
| 123 | Genetic liability to schizophrenia is negatively associated with educational attainment in UK Biobank | 7.8 | 36 | Citations (PDF) |
| 124 | Altered white matter microstructure in 22q11.2 deletion syndrome: a multisite diffusion tensor imaging study | 7.8 | 70 | Citations (PDF) |
| 125 | Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection | 25.2 | 1,639 | Citations (PDF) |
| 126 | A data‐driven investigation of relationships between bipolar psychotic symptoms and schizophrenia genome‐wide significant genetic loci | 1.5 | 11 | Citations (PDF) |
| 127 | Association of copy number variation across the genome with neuropsychiatric traits in the general population | 1.5 | 32 | Citations (PDF) |
| 128 | Formalising recall by genotype as an efficient approach to detailed phenotyping and causal inference | 13.7 | 71 | Citations (PDF) |
| 129 | Effects of MiR‐137 genetic risk score on brain volume and cortical measures in patients with schizophrenia and controls | 1.5 | 12 | Citations (PDF) |
| 130 | Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression | 25.2 | 3,016 | Citations (PDF) |
| 131 | T128. THE ASSOCIATION BETWEEN GENETIC RISK FOR SCHIZOPHRENIA AND PATTERNS OF CIGARETTE AND CANNABIS USE IN ADOLESCENCE | 3.9 | 1 | Citations (PDF) |
| 132 | 9.1 GENOMICS AND PSYCHIATRIC DIAGNOSIS | 3.9 | 0 | Citations (PDF) |
| 133 | 9. DOES BIOLOGY READ THE DSM? TRANSDIAGNOSTIC FINDINGS IN PSYCHOSIS AND IMPLICATIONS FOR TREATMENT | 3.9 | 1 | Citations (PDF) |
| 134 | O4.8. VULNERABLE PERIODS FOR COGNITIVE DEVELOPMENT IN INDIVIDUALS AT HIGH GENOMIC RISK OF SCHIZOPHRENIA | 3.9 | 0 | Citations (PDF) |
| 135 | F138. INVESTIGATING A CAUSAL ASSOCIATION BETWEEN NEUROTICISM AND SCHIZOPHRENIA USING TWO-SAMPLE MENDELIAN RANDOMIZATION | 3.9 | 0 | Citations (PDF) |
| 136 | Expression quantitative trait loci in the developing human brain and their enrichment in neuropsychiatric disorders | 8.1 | 156 | Citations (PDF) |
| 137 | Effects of pathogenic CNVs on physical traits in participants of the UK Biobank | 3.2 | 79 | Citations (PDF) |
| 138 | Integrative functional genomic analysis of human brain development and neuropsychiatric risks | 36.2 | 760 | Citations (PDF) |
| 139 | Variance of IQ is partially dependent on deletion type among 1,427 22q11.2 deletion syndrome subjects | 1.5 | 44 | Citations (PDF) |
| 140 | Examining cognition across the bipolar/schizophrenia diagnostic spectrum | 2.1 | 63 | Citations (PDF) |
| 141 | Genetic identification of brain cell types underlying schizophrenia | 25.2 | 700 | Citations (PDF) |
| 142 | Analysis of shared heritability in common disorders of the brain | 36.2 | 1,407 | Citations (PDF) |
| 143 | Premature mortality among people with severe mental illness — New evidence from linked primary care data | 2.3 | 179 | Citations (PDF) |
| 144 | Investigating the genetic architecture of general and specific psychopathology in adolescence | 5.2 | 61 | Citations (PDF) |
| 145 | Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size | 7.8 | 180 | Citations (PDF) |
| 146 | PEMapper and PECaller provide a simplified approach to whole-genome sequencing | 7.5 | 33 | Citations (PDF) |
| 147 | A review of psychiatric co-morbidity described in genetic and immune mediated movement disorders | 6.8 | 12 | Citations (PDF) |
| 148 | Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia | 5.2 | 191 | Citations (PDF) |
| 149 | Genetic effects influencing risk for major depressive disorder in China and Europe | 5.2 | 75 | Citations (PDF) |
| 150 | Mutation intolerant genes and targets of FMRP are enriched for nonsynonymous alleles in schizophrenia | 1.5 | 22 | Citations (PDF) |
| 151 | Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease | 25.2 | 1,010 | Citations (PDF) |
| 152 | Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome | 8.8 | 89 | Citations (PDF) |
| 153 | The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability | 25.2 | 243 | Citations (PDF) |
| 154 | Cognitive Performance Among Carriers of Pathogenic Copy Number Variants: Analysis of 152,000 UK Biobank Subjects | 5.4 | 224 | Citations (PDF) |
| 155 | The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia | 5.4 | 564 | Citations (PDF) |
| 156 | Gender differences in CNV burden do not confound schizophrenia CNV associations | 3.4 | 14 | Citations (PDF) |
| 157 | Associations between polygenic risk for schizophrenia and brain function during probabilistic learning in healthy individuals | 3.5 | 28 | Citations (PDF) |
| 158 | Analysis of Intellectual Disability Copy Number Variants for Association With Schizophrenia | 12.4 | 165 | Citations (PDF) |
| 159 | Reasons for discontinuing clozapine: A cohort study of patients commencing treatment | 2.3 | 141 | Citations (PDF) |
| 160 | Mutation screening of SCN2A in schizophrenia and identification of a novel loss-of-function mutation | 1.3 | 54 | Citations (PDF) |
| 161 | Schizophrenia | 62.1 | 1,842 | Citations (PDF) |
| 162 | Charting the landscape of priority problems in psychiatry, part 1: classification and diagnosis | 17.3 | 167 | Citations (PDF) |
| 163 | Evidence of Common Genetic Overlap Between Schizophrenia and Cognition | 3.9 | 121 | Citations (PDF) |
| 164 | Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders | 17.1 | 460 | Citations (PDF) |
| 165 | Phenotypic Manifestation of Genetic Risk for Schizophrenia During Adolescence in the General Population | 12.4 | 245 | Citations (PDF) |
| 166 | Mental health resilience in the adolescent offspring of parents with depression: a prospective longitudinal study | 17.3 | 154 | Citations (PDF) |
| 167 | Exome arrays capture polygenic rare variant contributions to schizophrenia | 2.9 | 58 | Citations (PDF) |
| 168 | Defining the Effect of the 16p11.2 Duplication on Cognition, Behavior, and Medical Comorbidities | 12.4 | 274 | Citations (PDF) |
| 169 | Schizophrenia copy number variants and associative learning | 7.8 | 19 | Citations (PDF) |
| 170 | Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects | 25.2 | 1,079 | Citations (PDF) |
| 171 | Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia | 7.8 | 88 | Citations (PDF) |
| 172 | The clinical presentation of attention deficit‐hyperactivity disorder (ADHD) in children with 22q11.2 deletion syndrome | 1.5 | 43 | Citations (PDF) |
| 173 | No Evidence for Enrichment in Schizophrenia for Common Allelic Associations at Imprinted Loci | 2.3 | 5 | Citations (PDF) |
| 174 | Evaluating historical candidate genes for schizophrenia | 7.8 | 311 | Citations (PDF) |
| 175 | Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia | 11.0 | 199 | Citations (PDF) |
| 176 | A genetic risk score combining 32 SNPs is associated with body mass index and improves obesity prediction in people with major depressive disorder | 7.1 | 64 | Citations (PDF) |
| 177 | Genetic overlap between Alzheimer’s disease and Parkinson’s disease at the MAPT locus | 7.8 | 156 | Citations (PDF) |
| 178 | Analysis of exome sequence in 604 trios for recessive genotypes in schizophrenia | 5.2 | 38 | Citations (PDF) |
| 179 | A national population-based e-cohort of people with psychosis (PsyCymru) linking prospectively ascertained phenotypically rich and genetic data to routinely collected records: Overview, recruitment and linkage | 2.3 | 14 | Citations (PDF) |
| 180 | Shared Genetic Influences Between Attention-Deficit/Hyperactivity Disorder (ADHD) Traits in Children and Clinical ADHD | 2.3 | 92 | Citations (PDF) |
| 181 | Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders | 5.8 | 219 | Citations (PDF) |
| 182 | Schizophrenia Genetics: Building the Foundations of the Future | 3.9 | 8 | Citations (PDF) |
| 183 | Genetics of schizophrenia | 2.8 | 49 | Citations (PDF) |
| 184 | Genetic Risk for Schizophrenia: Convergence on Synaptic Pathways Involved in Plasticity | 5.4 | 289 | Citations (PDF) |
| 185 | Copy number variation in bipolar disorder | 7.8 | 170 | Citations (PDF) |
| 186 | Psychiatric gene discoveries shape evidence on ADHD’s biology | 7.8 | 62 | Citations (PDF) |
| 187 | Common alleles contribute to schizophrenia in CNV carriers | 7.8 | 119 | Citations (PDF) |
| 188 | Identifying Gene-Environment Interactions in Schizophrenia: Contemporary Challenges for Integrated, Large-scale Investigations | 3.9 | 254 | Citations (PDF) |
| 189 | A Population-Based Study of Genetic Variation and Psychotic Experiences in Adolescents | 3.9 | 91 | Citations (PDF) |
| 190 | CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1 | 2.9 | 127 | Citations (PDF) |
| 191 | Psychiatric Disorders From Childhood to Adulthood in 22q11.2 Deletion Syndrome: Results From the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome | 8.8 | 781 | Citations (PDF) |
| 192 | De novo CNVs in bipolar affective disorder and schizophrenia | 2.9 | 79 | Citations (PDF) |
| 193 | Common variant at 16p11.2 conferring risk of psychosis | 7.8 | 98 | Citations (PDF) |
| 194 | The Penetrance of Copy Number Variations for Schizophrenia and Developmental Delay | 5.4 | 362 | Citations (PDF) |
| 195 | Genetic Relationships Between Schizophrenia, Bipolar Disorder, and Schizoaffective Disorder | 3.9 | 282 | Citations (PDF) |
| 196 | De novo mutations in schizophrenia implicate synaptic networks | 37.9 | 1,676 | Citations (PDF) |
| 197 | Synaptic, transcriptional and chromatin genes disrupted in autism | 37.9 | 2,765 | Citations (PDF) |
| 198 | Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice | 9.6 | 215 | Citations (PDF) |
| 199 | Copy number variation in schizophrenia in Sweden | 7.8 | 272 | Citations (PDF) |
| 200 | Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome | 2.3 | 94 | Citations (PDF) |
| 201 | Schizophrenia genetics: emerging themes for a complex disorder | 7.8 | 88 | Citations (PDF) |
| 202 | Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease | 25.2 | 4,442 | Citations (PDF) |
| 203 | Schizoaffective Disorder in the DSM-5 | 2.3 | 136 | Citations (PDF) |
| 204 | Definition and description of schizophrenia in the DSM-5 | 2.3 | 717 | Citations (PDF) |
| 205 | Implication of a Rare Deletion at Distal 16p11.2 in Schizophrenia | 12.4 | 106 | Citations (PDF) |
| 206 | Schizophrenia two‐hit hypothesis in velo‐cardio facial syndrome | 1.5 | 23 | Citations (PDF) |
| 207 | Non-random mating, parent-of-origin, and maternal–fetal incompatibility effects in schizophrenia | 2.3 | 1 | Citations (PDF) |
| 208 | The internet is parents' main source of information about psychiatric manifestations of 22q11.2 deletion syndrome (22q11.2DS) | 1.6 | 27 | Citations (PDF) |
| 209 | Variation in tau isoform expression in different brain regions and disease states | 3.4 | 60 | Citations (PDF) |
| 210 | The ENCODE project: implications for psychiatric genetics | 7.8 | 24 | Citations (PDF) |
| 211 | Evidence that duplications of 22q11.2 protect against schizophrenia | 7.8 | 209 | Citations (PDF) |
| 212 | Specific Parental Depression Symptoms as Risk Markers for New-Onset Depression in High-Risk Offspring | 1.8 | 2 | Citations (PDF) |
| 213 | A Population-Based Study of Shared Genetic Variation Between Premorbid IQ and Psychosis Among Male Twin Pairs and Sibling Pairs From Sweden | 12.7 | 57 | Citations (PDF) |
| 214 | De Novo Mutation in Schizophrenia | 3.9 | 51 | Citations (PDF) |
| 215 | Permutation-based approaches do not adequately allow for linkage disequilibrium in gene-wide multi-locus association analysis | 3.0 | 20 | Citations (PDF) |
| 216 | Genome-Wide Analysis of Copy Number Variants in Attention Deficit Hyperactivity Disorder: The Role of Rare Variants and Duplications at 15q13.3 | 8.8 | 266 | Citations (PDF) |
| 217 | The Role of Variation at AβPP, PSEN1, PSEN2, and MAPT in Late Onset Alzheimer's Disease | 2.6 | 58 | Citations (PDF) |
| 218 | Clusterin mRNA and Protein in Alzheimer's Disease | 2.6 | 24 | Citations (PDF) |
| 219 | Implications of Genetic Findings for Understanding Schizophrenia | 3.9 | 49 | Citations (PDF) |
| 220 | Discovery and Statistical Genotyping of Copy-Number Variation from Whole-Exome Sequencing Depth | 6.5 | 571 | Citations (PDF) |
| 221 | Independent estimation of the frequency of rare CNVs in the UK population confirms their role in schizophrenia | 2.3 | 76 | Citations (PDF) |
| 222 | Trajectories of change in self-reported psychotic-like experiences in childhood and adolescence | 2.3 | 60 | Citations (PDF) |
| 223 | Recent genomic advances in schizophrenia | 2.1 | 86 | Citations (PDF) |
| 224 | The health informatics cohort enhancement project (HICE): using routinely collected primary care data to identify people with a lifetime diagnosis of psychotic disorder | 1.5 | 19 | Citations (PDF) |
| 225 | Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC | 7.8 | 236 | Citations (PDF) |
| 226 | DCLK1 Variants Are Associated across Schizophrenia and Attention Deficit/Hyperactivity Disorder | 2.3 | 35 | Citations (PDF) |
| 227 | Is there a schizophrenia to diagnose? | 53.7 | 9 | Citations (PDF) |
| 228 | Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries | 2.9 | 236 | Citations (PDF) |
| 229 | Genome-Wide Association Study of Schizophrenia in a Japanese Population | 5.4 | 161 | Citations (PDF) |
| 230 | An Examination of Single Nucleotide Polymorphism Selection Prioritization Strategies for Tests of Gene–Gene Interaction | 5.4 | 10 | Citations (PDF) |
| 231 | De Novo Rates and Selection of Schizophrenia-Associated Copy Number Variants | 5.4 | 89 | Citations (PDF) |
| 232 | A Multi-Center Study of ACE and the Risk of Late-Onset Alzheimer's Disease | 2.6 | 36 | Citations (PDF) |
| 233 | Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease | 25.2 | 1,946 | Citations (PDF) |
| 234 | Investigation of rare non-synonymous variants at ABCA13 in schizophrenia and bipolar disorder | 7.8 | 18 | Citations (PDF) |
| 235 | A family-based study of common polygenic variation and risk of schizophrenia | 7.8 | 28 | Citations (PDF) |
| 236 | Genetic variants in the ErbB4 gene are associated with white matter integrity | 1.9 | 39 | Citations (PDF) |
| 237 | Mutation screening of the 3q29 microdeletion syndrome candidate genes DLG1 and PAK2 in schizophrenia | 1.5 | 33 | Citations (PDF) |
| 238 | Phenotype evaluation and genomewide linkage study of clinical variables in schizophrenia | 1.5 | 16 | Citations (PDF) |
| 239 | De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia | 7.8 | 856 | Citations (PDF) |
| 240 | Depressive disorder moderates the effect of the FTO gene on body mass index | 7.8 | 80 | Citations (PDF) |
| 241 | Mutation screening of the DTNBP1 exonic sequence in 669 schizophrenics and 710 controls using high‐resolution melting analysis | 1.5 | 12 | Citations (PDF) |
| 242 | Rare Copy Number Variants<subtitle>A Point of Rarity in Genetic Risk for Bipolar Disorder and Schizophrenia</subtitle><alt-title>Rare Copy Number Variants</alt-title> | 12.7 | 178 | Citations (PDF) |
| 243 | Distribution and Expression of Picalm in Alzheimer Disease | 1.8 | 106 | Citations (PDF) |
| 244 | No evidence that rare coding variants inZNF804Aconfer risk of schizophrenia | 1.5 | 18 | Citations (PDF) |
| 245 | TCF4, Schizophrenia, and Pitt-Hopkins Syndrome | 3.9 | 71 | Citations (PDF) |
| 246 | Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease | 16.5 | 1,155 | Citations (PDF) |
| 247 | Suggestion of Roles for Both Common and Rare Risk Variants in Genome-wide Studies of Schizophrenia | 12.7 | 120 | Citations (PDF) |
| 248 | Genotype Link With Extreme Antisocial Behavior | 12.7 | 57 | Citations (PDF) |
| 249 | Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis | 62.1 | 550 | Citations (PDF) |
| 250 | Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder | 7.8 | 166 | Citations (PDF) |
| 251 | Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder | 7.8 | 258 | Citations (PDF) |
| 252 | Molecular Genetics and the Kraepelinian Dichotomy: One Disorder, Two Disorders, or Do We Need to Start Thinking Afresh? | 0.3 | 8 | Citations (PDF) |
| 253 | Genes of the serotonergic and dopaminergic pathways and their interaction affect the expression of Behavioural and Psychological Symptoms in Dementia (BPSD). | 0.0 | 0 | Citations (PDF) |
| 254 | New findings from genetic association studies of schizophrenia | 2.0 | 29 | Citations (PDF) |
| 255 | Neurexin 1 (NRXN1) Deletions in Schizophrenia | 3.9 | 230 | Citations (PDF) |
| 256 | Support for the involvement of large copy number variants in the pathogenesis of schizophrenia | 2.9 | 383 | Citations (PDF) |
| 257 | Depression Case Control (DeCC) Study fails to support involvement of the muscarinic acetylcholine receptor M2 (CHRM2) gene in recurrent major depressive disorder | 2.9 | 56 | Citations (PDF) |
| 258 | Schizophrenia genetics: new insights from new approaches | 3.9 | 62 | Citations (PDF) |
| 259 | Case-control association study of 65 candidate genes revealed a possible association of a SNP of HTR5A to be a factor susceptible to bipolar disease in Bulgarian population | 4.5 | 42 | Citations (PDF) |
| 260 | Evidence that putative ADHD low risk alleles atSNAP25may increase the risk of schizophrenia | 1.5 | 31 | Citations (PDF) |
| 261 | An association study of common variation at the MAPT locus with late‐onset Alzheimer's disease | 1.5 | 35 | Citations (PDF) |
| 262 | Genetics of psychosis; insights from views across the genome | 2.9 | 201 | Citations (PDF) |
| 263 | Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease | 25.2 | 2,941 | Citations (PDF) |
| 264 | Microduplications of 16p11.2 are associated with schizophrenia | 25.2 | 700 | Citations (PDF) |
| 265 | Mood‐incongruent psychosis in bipolar disorder: conditional linkage analysis shows genome‐wide suggestive linkage at 1q32.3, 7p13 and 20q13.31 | 2.1 | 24 | Citations (PDF) |
| 266 | Gene Ontology Analysis of GWA Study Data Sets Provides Insights into the Biology of Bipolar Disorder | 6.5 | 373 | Citations (PDF) |
| 267 | Schizophrenia genetics: advancing on two fronts | 3.2 | 69 | Citations (PDF) |
| 268 | Evidence that variation in the oligodendrocyte lineage transcription factor 2 (OLIG2) gene is associated with psychosis in Alzheimer's disease | 1.9 | 34 | Citations (PDF) |
| 269 | Genetic overlap between autism, schizophrenia and bipolar disorder | 9.6 | 308 | Citations (PDF) |
| 270 | The effect of age and the H1c MAPT haplotype on MAPT expression in human brain | 3.4 | 21 | Citations (PDF) |
| 271 | Psychosis Genetics: Modeling the Relationship Between Schizophrenia, Bipolar Disorder, and Mixed (or "Schizoaffective") Psychoses | 3.9 | 204 | Citations (PDF) |
| 272 | Letter to the Editor: Strong evidence for multiple psychosis susceptibility genes – a rejoinder to Crow | 0.0 | 1 | Citations (PDF) |
| 273 | Psychopathy trait scores in adolescents with childhood ADHD: the contribution of genotypes affecting MAOA, 5HTT and COMT activity | 1.3 | 94 | Citations (PDF) |
| 274 | The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia | 7.8 | 492 | Citations (PDF) |
| 275 | Evidence for rare and common genetic risk variants for schizophrenia at protein kinase C, alpha | 7.8 | 33 | Citations (PDF) |
| 276 | Association study in the 5q31-32 linkage region for schizophrenia using pooled DNA genotyping | 3.1 | 26 | Citations (PDF) |
| 277 | A genome-wide association study for late-onset Alzheimer's disease using DNA pooling | 1.7 | 171 | Citations (PDF) |
| 278 | Testing for gene × environment interaction effects in attention deficit hyperactivity disorder and associated antisocial behavior | 1.5 | 58 | Citations (PDF) |
| 279 | DISC1 mRNA expression is not influenced by common Cis‐acting regulatory polymorphisms or imprinting | 1.5 | 9 | Citations (PDF) |
| 280 | Identification of loci associated with schizophrenia by genome-wide association and follow-up | 25.2 | 1,026 | Citations (PDF) |
| 281 | Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder | 25.2 | 1,192 | Citations (PDF) |
| 282 | A comparison of four clustering methods for brain expression microarray data | 3.0 | 28 | Citations (PDF) |
| 283 | Genetics of schizophrenia | 0.3 | 1 | Citations (PDF) |
| 284 | SORL1 variants and risk of late-onset Alzheimer’s disease | 5.1 | 78 | Citations (PDF) |
| 285 | Genome-Wide Association Identifies a Common Variant in the Reelin Gene That Increases the Risk of Schizophrenia Only in Women | 3.2 | 315 | Citations (PDF) |
| 286 | Strong evidence that GNB1L is associated with schizophrenia | 2.9 | 65 | Citations (PDF) |
| 287 | Analysis of copy number variation using quantitative interspecies competitive PCR | 15.5 | 9 | Citations (PDF) |
| 288 | Cis- and trans- loci influence expression of the schizophrenia susceptibility gene DTNBP1 | 2.9 | 18 | Citations (PDF) |
| 289 | Autism-associated SNPs in the clock genes npas2, per1 and the homeobox gene en2 alter DNA sequences that show characteristics of microRNA genes. | 0.0 | 1 | Citations (PDF) |
| 290 | Molecular genetic contribution to the developmental course of attention-deficit hyperactivity disorder | 3.1 | 38 | Citations (PDF) |
| 291 | Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk | 7.8 | 336 | Citations (PDF) |
| 292 | A genome-wide association study in 574 schizophrenia trios using DNA pooling | 7.8 | 140 | Citations (PDF) |
| 293 | Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2 | 7.8 | 69 | Citations (PDF) |
| 294 | Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype | 7.8 | 117 | Citations (PDF) |
| 295 | Promoting Measured Genes and Measured Environments: On the Importance of Careful Statistical Analyses and Biological Relevance—Reply | 12.7 | 3 | Citations (PDF) |
| 296 | Birth order and the severity of illness in schizophrenia | 3.1 | 11 | Citations (PDF) |
| 297 | Is COMT a Susceptibility Gene for Schizophrenia? | 3.9 | 164 | Citations (PDF) |
| 298 | Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia | 2.9 | 354 | Citations (PDF) |
| 299 | The Genetic Deconstruction of Psychosis | 3.9 | 246 | Citations (PDF) |
| 300 | Association analysis of the glial cell line-derived neurotrophic factor (GDNF) gene in schizophrenia | 2.3 | 21 | Citations (PDF) |
| 301 | Association studies of 23 positional/functional candidate genes on chromosome 10 in late‐onset Alzheimer's disease | 1.5 | 45 | Citations (PDF) |
| 302 | Association of Per1 and Npas2 with autistic disorder: support for the clock genes/social timing hypothesis | 7.8 | 170 | Citations (PDF) |
| 303 | Agreement between maternal report and antenatal records for a range of pre and peri-natal factors: The influence of maternal and child characteristics | 1.9 | 166 | Citations (PDF) |
| 304 | Complement Factor H Y402H Polymorphism is not Associated with Late-onset Alzheimer’s Disease | 3.6 | 22 | Citations (PDF) |
| 305 | Genes for Schizophrenia and Bipolar Disorder? Implications for Psychiatric Nosology | 3.9 | 443 | Citations (PDF) |
| 306 | Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD) | 2.9 | 548 | Citations (PDF) |
| 307 | Reply to Bertram et al. | 6.5 | 4 | Citations (PDF) |
| 308 | Analysis of ProDH, COMT and ZDHHC8 risk variants does not support individual or interactive effects on schizophrenia susceptibility | 2.3 | 39 | Citations (PDF) |
| 309 | Convergent Evidence for 2′,3′-Cyclic Nucleotide 3′-Phosphodiesterase as a Possible Susceptibility Gene for Schizophrenia | 12.7 | 120 | Citations (PDF) |
| 310 | An update on the genetics of schizophrenia | 4.2 | 132 | Citations (PDF) |
| 311 | Variation at the DAOA/G30 Locus Influences Susceptibility to Major Mood Episodes but Not Psychosis in Schizophrenia and Bipolar Disorder | 12.7 | 140 | Citations (PDF) |
| 312 | The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons | 7.8 | 208 | Citations (PDF) |
| 313 | Evidence that a DISC1 frame-shift deletion associated with psychosis in a single family may not be a pathogenic mutation | 7.8 | 30 | Citations (PDF) |
| 314 | Four Components Describe Behavioral Symptoms in 1,120 Individuals with Late‐Onset Alzheimer's Disease | 2.9 | 136 | Citations (PDF) |
| 315 | Pooled DNA genotyping on Affymetrix SNP genotyping arrays | 3.2 | 75 | Citations (PDF) |
| 316 | Chromosome 22 Deletion Syndrome And Schizophrenia | 3.1 | 15 | Citations (PDF) |
| 317 | Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia | 7.5 | 125 | Citations (PDF) |
| 318 | Operation of the Schizophrenia Susceptibility Gene, Neuregulin 1, Across Traditional Diagnostic Boundaries to Increase Risk for Bipolar Disorder | 12.7 | 232 | Citations (PDF) |
| 319 | Identification of a potential Bipolar risk haplotype in the gene encoding the winged-helix transcription factor RFX4 | 7.8 | 25 | Citations (PDF) |
| 320 | A cross-sectional and a prospective study of thyroid disorders in lithium-treated patients | 4.5 | 78 | Citations (PDF) |
| 321 | Schizophrenia: genes at last? | 9.8 | 281 | Citations (PDF) |
| 322 | No evidence for association between polymorphisms in GRM3and schizophrenia | 3.1 | 51 | Citations (PDF) |
| 323 | Genetics of schizophrenia | 0.3 | 3 | Citations (PDF) |
| 324 | Linkage disequilibrium mapping of bipolar affective disorder at 12q23-q24 provides evidence for association atCUX2 andFLJ32356 | 1.5 | 25 | Citations (PDF) |
| 325 | No support for association between the dopamine transporter (DAT1) gene and ADHD | 1.5 | 71 | Citations (PDF) |
| 326 | Is the Dysbindin Gene (DTNBP1) a Susceptibility Gene for Schizophrenia? | 3.9 | 102 | Citations (PDF) |
| 327 | No Association Between Schizophrenia and Polymorphisms in COMT in Two Large Samples | 8.8 | 76 | Citations (PDF) |
| 328 | Genomewide Linkage Scan in Schizoaffective Disorder | 12.7 | 181 | Citations (PDF) |
| 329 | Localization of Bipolar Susceptibility Locus by Molecular Genetic Analysis of the Chromosome 12q23-q24 Region in Two Pedigrees With Bipolar Disorder and Darier’s Disease | 8.8 | 56 | Citations (PDF) |
| 330 | The genetics of attention deficit hyperactivity disorder | 2.9 | 195 | Citations (PDF) |
| 331 | Catechol O-Methyltransferase Gene Variant and Birth Weight Predict Early-Onset Antisocial Behavior in Children With Attention-Deficit/Hyperactivity Disorder | 12.7 | 176 | Citations (PDF) |
| 332 | Strong Evidence That KIAA0319 on Chromosome 6p Is a Susceptibility Gene for Developmental Dyslexia | 6.5 | 271 | Citations (PDF) |
| 333 | Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression | 2.9 | 179 | Citations (PDF) |
| 334 | The genetics of schizophrenia and bipolar disorder: dissecting psychosis | 3.8 | 506 | Citations (PDF) |
| 335 | Genomic approaches to schizophrenia | 2.7 | 21 | Citations (PDF) |
| 336 | HTR2A: Association and expression studies in neuropsychiatric genetics | 3.8 | 90 | Citations (PDF) |
| 337 | Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1) | 5.4 | 120 | Citations (PDF) |
| 338 | A Family Based Study Implicates Solute Carrier Family 1–Member 3 (SLC1A3) Gene in Attention-Deficit/Hyperactivity Disorder | 5.4 | 28 | Citations (PDF) |
| 339 | Finding schizophrenia genes | 10.6 | 102 | Citations (PDF) |
| 340 | Family Aggregation of High Myopia: Estimation of the Sibling Recurrence Risk Ratio 2004, 45, 2873 | | 99 | Citations (PDF) |
| 341 | Brain Anatomy in Adults With Velocardiofacial Syndrome With and WithoutSchizophrenia | 12.7 | 144 | Citations (PDF) |
| 342 | Genetics: The implications for forensic psychiatry | 1.0 | 1 | Citations (PDF) |
| 343 | Association of the Dopamine D4Receptor Gene 7-Repeat Allele With Neuropsychological Test Performance of Children With ADHD | 8.8 | 165 | Citations (PDF) |
| 344 | Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes | 2.9 | 44 | Citations (PDF) |
| 345 | Linkage Analysis of the Genetic Loci for High Myopia on 18p, 12q, and 17q in 51 U.K. Families 2004, 45, 2879 | | 78 | Citations (PDF) |
| 346 | Identification in 2 Independent Samples of a Novel Schizophrenia RiskHaplotype of the Dystrobrevin Binding Protein Gene (DTNBP1) | 12.7 | 176 | Citations (PDF) |
| 347 | A functional polymorphism in the succinate-semialdehyde dehydrogenase (aldehyde dehydrogenase 5 family, member A1) gene is associated with cognitive ability | 7.8 | 47 | Citations (PDF) |
| 348 | Bipolar disorder among an isolated island community in Ethiopia | 4.5 | 28 | Citations (PDF) |
| 349 | No evidence of association between Catechol-O-Methyltransferase (COMT) Val 158 Met genotype and performance on neuropsychological tasks in children with ADHD: A case-control study | 3.1 | 37 | Citations (PDF) |
| 350 | Genetic abnormalities of chromosome 22 and the development of psychosis | 5.3 | 34 | Citations (PDF) |
| 351 | Direct analysis of the genes encoding G proteins G?T2, G?o, G?Z in ADHD | 0.5 | 3 | Citations (PDF) |
| 352 | Association analysis of two candidate phospholipase genes that map to the chromosome 15q15.1-15.3 region associated with reading disability | 0.5 | 15 | Citations (PDF) |
| 353 | DNA pooling as a tool for large‐scale association studies in complex traits | 3.8 | 69 | Citations (PDF) |
| 354 | Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria | 5.4 | 149 | Citations (PDF) |
| 355 | Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome | 2.3 | 87 | Citations (PDF) |
| 356 | TBP, a polyglutamine tract containing protein, accumulates in Alzheimer's disease | 2.6 | 23 | Citations (PDF) |
| 357 | No support for association between Dyslexia Susceptibility 1 Candidate 1 and developmental dyslexia | 7.8 | 50 | Citations (PDF) |
| 358 | Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment | 2.6 | 34 | Citations (PDF) |
| 359 | Cis-acting variation in the expression of a high proportion of genes in human brain | 2.9 | 214 | Citations (PDF) |
| 360 | Mutation screening of the Homer gene family and association analysis in schizophrenia | 1.5 | 61 | Citations (PDF) |
| 361 | Detailed analysis of PRODH and PsPRODH reveals no association with schizophrenia | 0.5 | 48 | Citations (PDF) |
| 362 | Association between PRODH and schizophrenia is not confirmed | 7.8 | 52 | Citations (PDF) |
| 363 | Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia | 7.8 | 229 | Citations (PDF) |
| 364 | Association between a promoter variant in the monoamine oxidase A gene and schizophrenia | 2.3 | 49 | Citations (PDF) |
| 365 | Self-reported schizotypy and bipolar disorder: demonstration of a lack of specificity of the Kings Schizotypy Questionnaire | 2.3 | 18 | Citations (PDF) |
| 366 | Genes for schizophrenia? Recent findings and their pathophysiological implications | 62.1 | 561 | Citations (PDF) |
| 367 | Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: Schizophrenia | 6.5 | 1,087 | Citations (PDF) |
| 368 | A Haplotype Implicated in Schizophrenia Susceptibility Is Associated with Reduced COMT Expression in Human Brain | 6.5 | 331 | Citations (PDF) |
| 369 | A Systematic Genomewide Linkage Study in 353 Sib Pairs with Schizophrenia | 6.5 | 115 | Citations (PDF) |
| 370 | Variation in the protocadherin γ A gene cluster☆ | 2.8 | 12 | Citations (PDF) |
| 371 | Recent advances in the genetics of schizophrenia | 2.9 | 138 | Citations (PDF) |
| 372 | Title is missing! | 1.3 | 1 | Citations (PDF) |
| 373 | The future of psychiatric genetics | 3.8 | 11 | Citations (PDF) |
| 374 | Mutational analysis of two positional candidate susceptibility genes for bipolar disorder on chromosome 12q23-q24 | 1.3 | 12 | Citations (PDF) |
| 375 | The serotonin-2A receptor gene locus does not contain common polymorphism affecting mRNA levels in adult brain | 7.8 | 100 | Citations (PDF) |
| 376 | The molecular genetics of schizophrenia: new findings promise new insights | 7.8 | 297 | Citations (PDF) |
| 377 | Hyperekplexia associated with compound heterozygote mutations in the beta-subunit of the human inhibitory glycine receptor (GLRB) | 2.9 | 179 | Citations (PDF) |
| 378 | Evidence for familial cosegregation of major affective disorder and genetic markers flanking the gene for Darier's disease | 7.8 | 68 | Citations (PDF) |
| 379 | Major psychiatric disorders and the serotonin transporter gene (SLC6A4): family-based association studies | 1.3 | 10 | Citations (PDF) |
| 380 | Title is missing! | 12.2 | 17 | Citations (PDF) |
| 381 | Familiality of clinical characteristics in schizophrenia | 2.9 | 25 | Citations (PDF) |
| 382 | An investigation of the neuropsychological profile in adults with velo-cardio-facial syndrome (VCFS) | 1.7 | 105 | Citations (PDF) |
| 383 | Universal, robust, highly quantitative SNP allele frequency measurement in DNA pools | 2.9 | 160 | Citations (PDF) |
| 384 | Determination of the genomic structure and mutation screening in schizophrenic individuals for five subunits of the N-methyl-D-aspartate glutamate receptor | 7.8 | 100 | Citations (PDF) |
| 385 | Evidence to suggest biased phenotypes in children with Attention Deficit Hyperactivity Disorder from completely ascertained trios | 7.8 | 22 | Citations (PDF) |
| 386 | Mutation screening and LD mapping in the VCFS deleted region of chromosome 22q11 in schizophrenia using a novel DNA pooling approach | 7.8 | 19 | Citations (PDF) |
| 387 | DNA Pooling: a tool for large-scale association studies | 46.9 | 550 | Citations (PDF) |
| 388 | Title is missing! 2002 | | 1 | Citations (PDF) |
| 389 | Familiality of symptom dimensions in schizophrenia | 2.3 | 78 | Citations (PDF) |
| 390 | Sustained and selective attention as measures of genetic liability to schizophrenia | 2.3 | 31 | Citations (PDF) |
| 391 | Searching for susceptibility genes in schizophrenia | 1.0 | 18 | Citations (PDF) |
| 392 | DR3 Regulates Negative Selection during Thymocyte Development | 2.5 | 115 | Citations (PDF) |
| 393 | No association between apolipoprotein E polymorphisms and general cognitive ability in children | 1.9 | 65 | Citations (PDF) |
| 394 | Susceptibility genes for a trait measure of attention deficit hyperactivity disorder: a pilot study in a non-clinical sample of twins | 3.1 | 30 | Citations (PDF) |
| 395 | Searching for schizophrenia genes | 7.4 | 59 | Citations (PDF) |
| 396 | Genomic structure, expression, and chromosome mapping of the mouse homologue for the WSL-1 ( DR3 , Apo3 , TRAMP , LARD , TR3 , TNFRSF12 ) gene | 2.8 | 30 | Citations (PDF) |
| 397 | Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease | 2.9 | 93 | Citations (PDF) |
| 398 | Compound heterozygosity and nonsense mutations in the α1-subunit of the inhibitory glycine receptor in hyperekplexia | 2.9 | 75 | Citations (PDF) |
| 399 | CUX2, a potential regulator of NCAM expression: Genomic characterization and analysis as a positional candidate susceptibility gene for bipolar disorder | 0.5 | 21 | Citations (PDF) |
| 400 | Allelic variation of aBalI polymorphism in the DRD3 gene does not influence susceptibility to bipolar disorder: Results of analysis and meta-analysis | 0.5 | 25 | Citations (PDF) |
| 401 | A genomewide linkage study of age at onset in schizophrenia | 0.5 | 64 | Citations (PDF) |
| 402 | Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: A family-based study | 0.5 | 114 | Citations (PDF) |
| 403 | Title is missing! | 1.3 | 83 | Citations (PDF) |
| 404 | Screening ABCG1, the human homologue of the Drosophila white gene, for polymorphisms and association with bipolar affective disorder | 7.8 | 18 | Citations (PDF) |
| 405 | Loss of Smad4 Function in Pancreatic Tumors | 2.2 | 90 | Citations (PDF) |
| 406 | Association analysis of the proneurotensin gene and bipolar disorder | 1.3 | 3 | Citations (PDF) |
| 407 | Bipolar disorder and variation at a common polymorphism (A1832G) within exon 8 of the Wolfram gene 2000, 96, 154-157 | | 32 | Citations (PDF) |
| 408 | No evidence of association from transmission disequilibrium analysis of the hKCa3
gene in bipolar disorder | 2.1 | 3 | Citations (PDF) |
| 409 | Psychiatric genetics: back to the future | 7.8 | 75 | Citations (PDF) |
| 410 | A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers | 2.9 | 123 | Citations (PDF) |
| 411 | Cheap, accurate and rapid allele frequency estimation of single nucleotide polymorphisms by primer extension and DHPLC in DNA pools | 2.9 | 164 | Citations (PDF) |
| 412 | Linkage analysis in an autosomal dominant ‘zonular nuclear pulverulent’ congenital cataract, mapped to chromosome 13q11-13 | 2.1 | 3 | Citations (PDF) |
| 413 | Molecular genetic studies of schizophrenia | 6.0 | 24 | Citations (PDF) |
| 414 | Multicenter Linkage Study of Schizophrenia Candidate Regions on Chromosomes 5q, 6q, 10p, and 13q: Schizophrenia Linkage Collaborative Group III **The Schizophrenia Linkage Collaborative Group III includes all authors, who are listed in the following order: study coordinators (Levinson, Holmans), principal investigators of each research group (Straub, Owen, Wildenauer, Gejman, Pulver, Laurent), and additional authors from each group, with groups listed according to the number of pedigrees contributed. Partic | 6.5 | 200 | Citations (PDF) |
| 415 | Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3) | 2.7 | 48 | Citations (PDF) |
| 416 | Further evidence of autosomal dominant congenital zonular pulverulent cataracts linked to 13q11 (CZP3) and a novel mutation in connexin 46 (GJA3) | 2.9 | 71 | Citations (PDF) |
| 417 | The Kings Schizotypy Questionnaire as a quantitative measure of schizophrenia liability | 2.3 | 17 | Citations (PDF) |
| 418 | Exclusion of the Darier's disease gene, ATP2A2, as a common susceptibility gene for bipolar disorder | 7.8 | 49 | Citations (PDF) |
| 419 | Dimensions of Psychosis in Affected Sibling Pairs | 3.9 | 69 | Citations (PDF) |
| 420 | Dopamine receptors and schizophrenia: contribution of molecular genetics and clinical neuropsychology | 2.7 | 14 | Citations (PDF) |
| 421 | DNA Pooling Identifies QTLs on Chromosome 4 for General Cognitive Ability in Children | 2.9 | 91 | Citations (PDF) |
| 422 | ATP2A2 Mutations in Darier's Disease and Their Relationship to Neuropsychiatric Phenotypes | 2.9 | 150 | Citations (PDF) |
| 423 | A Two-Stage Genome Scan for Schizophrenia Susceptibility Genes in 196 Affected Sibling Pairs | 2.9 | 139 | Citations (PDF) |
| 424 | Tryptophan Hydroxylase Gene and Manic-Depressive Illness | 12.7 | 33 | Citations (PDF) |
| 425 | High Rates of Schizophrenia in Adults With Velo-Cardio-Facial Syndrome | 12.7 | 972 | Citations (PDF) |
| 426 | Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease | 25.2 | 275 | Citations (PDF) |
| 427 | Mutational analysis of phospholipase A2A: a positional candidate susceptibility gene for bipolar disorder | 7.8 | 27 | Citations (PDF) |
| 428 | Autosome search for schizophrenia susceptibility genes in multiply affected families | 7.8 | 20 | Citations (PDF) |
| 429 | Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5 | 7.8 | 79 | Citations (PDF) |
| 430 | Genotyping single nucleotide polymorphisms by primer extension and high performance liquid chromatography | 2.9 | 102 | Citations (PDF) |
| 431 | No association between a polymorphic CAG repeat in the human potassium channel gene hKCa3 and bipolar disorder 1999, 88, 57-60 | | 18 | Citations (PDF) |
| 432 | Eleven trinucleotide repeat loci that map to chromosome 12 excluded from involvement in the pathogenesis of bipolar disorder 1999, 88, 67-70 | | 17 | Citations (PDF) |
| 433 | No evidence for allelic association between schizophrenia and a functional variant of the human dopamine ?-hydroxylase gene (DBH) 1999, 88, 557-559 | | 21 | Citations (PDF) |
| 434 | Candidate-Gene Association Studies of Schizophrenia | 6.5 | 118 | Citations (PDF) |
| 435 | CTG18.1 and ERDA-1 CAG/CTG Repeat Size in Bipolar Disorder | 5.1 | 17 | Citations (PDF) |
| 436 | A functional polymorphism in the promoter of monoamine oxidase A gene and bipolar affective disorder | 2.7 | 25 | Citations (PDF) |
| 437 | Title is missing! 1999 | | 1 | Citations (PDF) |
| 438 | Linked polymorphisms upstream of exons 1 and 2 of the human cholecystokinin gene are not associated with schizophrenia or bipolar disorder | 7.8 | 32 | Citations (PDF) |
| 439 | A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter | 7.8 | 235 | Citations (PDF) |
| 440 | Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine | 7.8 | 209 | Citations (PDF) |
| 441 | A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia | 7.8 | 166 | Citations (PDF) |
| 442 | A study of chromosome 4p markers and dopamine D5 receptor gene in schizophrenia and bipolar disorder | 7.8 | 72 | Citations (PDF) |
| 443 | A Simple Method for Analyzing Microsatellite Allele Image Patterns Generated from DNA Pools and Its Application to Allelic Association Studies | 6.5 | 121 | Citations (PDF) |
| 444 | The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease. | 3.8 | 28 | Citations (PDF) |
| 445 | Association between functional psychosis and expanded CAG/CTG repeats is not explained by health stratification | 1.3 | 2 | Citations (PDF) |
| 446 | Chromosome 11 workshop | 1.3 | 4 | Citations (PDF) |
| 447 | Association between schizophrenia and a microsatellite polymorphism at the dopamine D5 receptor gene | 1.3 | 22 | Citations (PDF) |
| 448 | Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia | 62.1 | 166 | Citations (PDF) |
| 449 | Factor-derived subsyndromes of schizophrenia and familial morbid risks | 2.3 | 54 | Citations (PDF) |
| 450 | Meta-analysis of association studies between schizophrenia and polymorphisms of the 5-hydroxytryptamine type 2A receptor gene | 2.3 | 0 | Citations (PDF) |
| 451 | Title is missing! | 1.3 | 32 | Citations (PDF) |
| 452 | Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers | 2.7 | 113 | Citations (PDF) |
| 453 | No evidence for an allelic association between schizophrenia and markers D22S278 and D22S283 1997, 74, 37-39 | | 14 | Citations (PDF) |
| 454 | Factor analysis of schizophrenic symptoms using the OPCRIT checklist | 2.3 | 69 | Citations (PDF) |
| 455 | A linkage study of schizophrenia with DNA markers from chromosome 8p21-p22 in 25 multiplex families | 2.3 | 17 | Citations (PDF) |
| 456 | Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene | 62.1 | 244 | Citations (PDF) |
| 457 | The Molecular Genetics of Schizophrenia | 3.8 | 18 | Citations (PDF) |
| 458 | Modern molecular genetic approaches to psychiatric disease | 3.9 | 45 | Citations (PDF) |
| 459 | The nature and nurture of depression: towards a new synthesis? | 2.6 | 1 | Citations (PDF) |
| 460 | Linkage analysis of the fragile X gene FMR-1 and schizophrenia | 1.3 | 12 | Citations (PDF) |
| 461 | Association study of bipolar disorder at the phospholipase A2 gene (PLA2A) in the Darierʼs disease (DAR) region of chromosome 12q23-q24.1 | 1.3 | 25 | Citations (PDF) |
| 462 | Association between a PS-1 intronic polymorphism and late onset Alzheimerʼs disease | 1.5 | 28 | Citations (PDF) |
| 463 | Introducing Selfcite 2.0—career enhancing software: Fig 1 | 0.1 | 8 | Citations (PDF) |
| 464 | Clinical features of early onset, familial Alzheimer's disease linked to chromosome 14 | 0.5 | 9 | Citations (PDF) |
| 465 | No evidence for allelic association between bipolar disorder and monoamine oxidase a gene polymorphisms | 0.5 | 66 | Citations (PDF) |
| 466 | Systematic search for major genes in schizophrenia: Methodological issues and results from chromosome 12 | 0.5 | 7 | Citations (PDF) |
| 467 | No evidence for linkage between the X-chromosome marker DXS7 and schizophrenia | 0.5 | 16 | Citations (PDF) |
| 468 | Expanded CAG repeats in schizophrenia and bipolar disorder | 25.2 | 212 | Citations (PDF) |
| 469 | The High Mobility Group Transcription Factor, SOX4, Transactivates the Human CD2 Enhancer | 2.2 | 43 | Citations (PDF) |
| 470 | No evidence that common allelic variation in the Amyloid Precursor Protein (APP) gene confers susceptibility to Alzheimer's disease | 2.9 | 23 | Citations (PDF) |
| 471 | Partial characterization and assignment of the gene for protoporphyrinogen oxidase and variegate porphyria to human chromosome 1q23 | 2.9 | 63 | Citations (PDF) |
| 472 | Allelic associations between 100 DNA markers and high versus low IQ | 2.3 | 81 | Citations (PDF) |
| 473 | Molecular Cloning and Tissue Expression ofFAT,the Human Homologue of theDrosophila fatGene That Is Located on Chromosome 4q34–q35 and Encodes a Putative Adhesion Molecule | 2.8 | 165 | Citations (PDF) |
| 474 | Genetic basis of schizophrenia | 62.1 | 291 | Citations (PDF) |
| 475 | Evidence for recessive as well as dominant forms of startle disease (hyperekplexia) caused by mutations in the α1 subunit of the inhibitory glycine receptor | 2.9 | 154 | Citations (PDF) |
| 476 | Genetic mapping on chromosome 22 | 2.3 | 0 | Citations (PDF) |
| 477 | Is there a link between schizophrenia and mutations at the fragile-X gene, FMR-1? | 2.3 | 0 | Citations (PDF) |
| 478 | Association and linkage: complementary strategies for complex disorders. | 3.8 | 52 | Citations (PDF) |
| 479 | Advances and Retreats in the Molecular Genetics of Major Mental Illness | 3.8 | 9 | Citations (PDF) |
| 480 | LOOKING FOR GENES IN SCHIZOPHRENIA | 1.1 | 1 | Citations (PDF) |
| 481 | Low birth weight and a family history of schizophrenia predict poor premorbid functioning in psychosis | 2.3 | 95 | Citations (PDF) |
| 482 | The molecular genetics of schizophrenia: An overview and forward view | 0.7 | 12 | Citations (PDF) |
| 483 | DNA-and classical genetic markers in schizophrenia | 0.7 | 13 | Citations (PDF) |
| 484 | A polymorphic microsatellite repeat sequence on chromosome 21 (D21S80) | 15.5 | 2 | Citations (PDF) |
| 485 | TCF-1, a T cell-specific transcription factor of the HMG box family, interacts with sequence motifs in the TCRβ and TCRδ enhancers | 3.1 | 54 | Citations (PDF) |
| 486 | Molecular genetic studies of manic-depression and schizophrenia | 9.8 | 15 | Citations (PDF) |
| 487 | What can the neurodevelopmental model explain? | 2.3 | 0 | Citations (PDF) |
| 488 | PREDISPOSING LOCUS FOR ALZHEIMER'S DISEASE ON CHROMOSOME 21 | 62.1 | 225 | Citations (PDF) |
| 489 | Modelling the occurrence and pathology of Alzheimer's disease | 3.4 | 8 | Citations (PDF) |
| 490 | Molecular Genetics and its Application to the Study of Psychiatric Disorders | 2.6 | 29 | Citations (PDF) |
| 491 | The Genetic Aetiology of Alzheimer's Disease | 2.6 | 4 | Citations (PDF) |
| 492 | Blue genes. | 0.1 | 1 | Citations (PDF) |
| 493 | Does amnesia after transection of the fornix in monkeys reflect abnormal sensitivity to proactive interference? | 2.2 | 47 | Citations (PDF) |
| 494 | Effects of Fornix Transection upon Associative Memory in Monkeys: Role of the Hippocampus in Learned Action | 4.8 | 157 | Citations (PDF) |
| 495 | Amnesia after transection of the fornix in monkeysLong-term memory impaired, short-term memory intact | 2.2 | 102 | Citations (PDF) |
| 496 | The effects of fornix lesions on latent learning in the rat | 2.2 | 9 | Citations (PDF) |
| 497 | The Relationship Between Polygenic Risk Scores and Cognition in Schizophrenia | 3.9 | 71 | Citations (PDF) |
| 498 | Title is missing! 0 | | 1 | Citations (PDF) |
| 499 | Sleep EEG in young people with 22q11.2 deletion syndrome: A cross-sectional study of slow-waves, spindles and correlations with memory and neurodevelopmental symptoms | 0.7 | 25 | Citations (PDF) |
| 500 | Title is missing! 0 | | 1 | Citations (PDF) |
| 501 | Genomics of schizophrenia, bipolar disorder and major depressive disorder | 46.9 | 31 | Citations (PDF) |
| 502 | Copy number variants and their implications for developmental and behavioural problems in cleft lip and/or palate | 2.9 | 5 | Citations (PDF) |
| 503 | Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length | 3.8 | 9 | Citations (PDF) |
| 504 | The influence of genetic factors on education health and care plan obtainment for pupils with intellectual developmental disabilities | 3.4 | 0 | Citations (PDF) |
| 505 | Psychiatric Nosology Should Include Genetic Syndromes | 5.4 | 0 | Citations (PDF) |
| 506 | Analysis of rare coding variants in schizophrenia-associated genes and generalised cognition in the UK Biobank | 7.8 | 1 | Citations (PDF) |
| 507 | Rethinking schizophrenia: insights from genomics and implications for research | 7.8 | 0 | Citations (PDF) |
| 508 | Genetic investigation of non-affective psychosis and depression as causal risk factors for dementia | 2.8 | 0 | Citations (PDF) |
